Zacks Investment Research on MSN
AGIO secures global rights to late-stage rare blood disorder candidate
Agios Pharmaceuticals AGIO has inked an agreement with Oscotec, a South Korea-based biotech, in-licensing exclusive global ...
InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) of ...
Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-US) pharmaceutical company, announced today the launch of TAVALISSE ® (fostamatinib disodium hexahydrate) in Mexico, for the ...
An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet ...
An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet ...
Growing insight into the antiplatelet properties of new nitric oxide (NO) donors has expanded their potential use in cardiovascular diseases. As such, we reported that oral administration of a new ...
A common over-the-counter medication combined with a home exercise program could help ease cognitive issues for cancer patients. That’s according to a study from the University of Rochester, which ...
OKLAHOMA CITY — Lakers superstar Luka Doncic spoke to reporters Wednesday for the first time since he suffered a Grade 2 hamstring strain April 2. Doncic revealed what led him to seek treatment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results